M&T BANK CORP - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 40 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q2 2020$149,000
+140.3%
13,3330.0%0.00%
Q1 2020$62,000
+8.8%
13,3330.0%0.00%
Q4 2019$57,000
+9.6%
13,3330.0%0.00%
Q3 2019$52,000
-1.9%
13,3330.0%0.00%
Q2 2019$53,000
-8.6%
13,3330.0%0.00%
Q1 2019$58,000
+23.4%
13,3330.0%0.00%
Q4 2018$47,000
-7.8%
13,3330.0%0.00%
Q3 2018$51,000
-1.9%
13,3330.0%0.00%
Q2 2018$52,000
+23.8%
13,3330.0%0.00%
Q1 2018$42,000
-19.2%
13,3330.0%0.00%
Q4 2017$52,000
-5.5%
13,3330.0%0.00%
Q3 2017$55,0000.0%13,3330.0%0.00%
Q2 2017$55,000
-3.5%
13,3330.0%0.00%
Q1 2017$57,000
+67.6%
13,3330.0%0.00%
Q4 2016$34,000
+6.2%
13,3330.0%0.00%
Q3 2016$32,0000.0%13,3330.0%0.00%
Q2 2016$32,000
-11.1%
13,3330.0%0.00%
Q1 2016$36,000
-5.3%
13,3330.0%0.00%
Q4 2015$38,000
+22.6%
13,3330.0%0.00%
Q3 2015$31,000
-35.4%
13,3330.0%0.00%
Q2 2015$48,000
-53.8%
13,333
-42.9%
0.00%
-100.0%
Q1 2015$104,000
-6.3%
23,3330.0%0.00%0.0%
Q4 2014$111,00023,3330.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q2 2018
NameSharesValueWeighting ↓
Perceptive Advisors 400,000$1,068,0000.09%
SABBY MANAGEMENT, LLC 493,191$1,317,0000.07%
GUARDIAN CAPITAL ADVISORS LP 10,000$23,0000.00%
A.R.T. Advisors, LLC 22,758$60,0000.00%
Psagot Value Holdings Ltd. 22,715$61,0000.00%
TCI Wealth Advisors, Inc. 1,100$3,0000.00%
Penserra Capital Management LLC 4,980$13,0000.00%
D'Orazio & Associates, Inc. 500$1,0000.00%
CITIGROUP INC 380$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 61,269$163,0000.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders